July 22, 2014

Sofosbuvir + ribavirin cures hepatitis C for more than 80% of people with HIV and HCV co-infection

People with HIV and hepatitis C virus co-infection experience more rapid liver disease progression than people with hepatitis C alone and do not respond as well to interferon-based therapy. An interferon-free regimen of sofosbuvir (Sovaldi) plus ribavirin for 24 weeks led to sustained hepatitis C virological response in 84 to 89% of HIV-positive people with chronic hepatitis C, according to the results of the phase 3 PHOTON-2 study, presented at AIDS 2014.

View the full post here.